227 related articles for article (PubMed ID: 11523419)
41. Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach.
Namiot DB; Namiot Z; Kemona A; Bucki R; Gotebiewska M
Helicobacter; 2007 Feb; 12(1):63-7. PubMed ID: 17241303
[TBL] [Abstract][Full Text] [Related]
42. Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis.
Ozdemir A; Mas MR; Sahin S; Sağlamkaya U; Ateşkan U
Quintessence Int; 2001 Feb; 32(2):131-4. PubMed ID: 12066673
[TBL] [Abstract][Full Text] [Related]
43. All PPIs equivalent for treatment of GERD.
J Fam Pract; 2005 Dec; 54(12):1024. PubMed ID: 16370078
[No Abstract] [Full Text] [Related]
44. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
[TBL] [Abstract][Full Text] [Related]
45. [Characteristics of a combined course of duodenal ulcer and gastroesophageal reflux disease].
Tsimmerman IaS; Vologzhanina LG
Klin Med (Mosk); 2007; 85(3):53-8. PubMed ID: 17523407
[TBL] [Abstract][Full Text] [Related]
46. Omeprazole. Overview and opinion.
Holt S; Howden CW
Dig Dis Sci; 1991 Apr; 36(4):385-93. PubMed ID: 2007354
[TBL] [Abstract][Full Text] [Related]
47. Omeprazole maintenance therapy for GERD.
Parks SM
J Fam Pract; 1997 Oct; 45(4):292-3. PubMed ID: 9379150
[No Abstract] [Full Text] [Related]
48. Criteria for use of omeprazole in adult inpatients and outpatients.
Lajoie C
Clin Pharm; 1992 Feb; 11(2):177-9. PubMed ID: 1551300
[No Abstract] [Full Text] [Related]
49. [Ulfamid in the combined therapy of gastric and duodenal peptic ulcer].
Pal'tsev AI; Maslennikova TA
Ter Arkh; 1997; 69(2):62-3. PubMed ID: 9173582
[No Abstract] [Full Text] [Related]
50. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
Carella G
Clin Ter; 1984 Mar; 108(6):525-9. PubMed ID: 6144411
[No Abstract] [Full Text] [Related]
51. [Omeprazole, the drug of the future for the treatment of Zollinger-Ellison syndrome and duodenal ulcer?].
Fiasse R; Tomé G; Dive C
Acta Gastroenterol Belg; 1984; 47(6):555-68. PubMed ID: 6537111
[No Abstract] [Full Text] [Related]
52. Omeprazole.
Maton PN
N Engl J Med; 1991 Apr; 324(14):965-75. PubMed ID: 2002819
[No Abstract] [Full Text] [Related]
53. [Omeprazole. Its pharmacology and therapeutic efficacy].
Protzer U; Holtermüller KH
Dtsch Med Wochenschr; 1993 Feb; 118(7):230-9. PubMed ID: 8440164
[No Abstract] [Full Text] [Related]
54. Combination sucralfate and histamine2-antagonist therapy.
Gales MA; Steadman BK
Ann Pharmacother; 1994 May; 28(5):597-600. PubMed ID: 7915150
[No Abstract] [Full Text] [Related]
55. Low-dose omeprazole for erosive esophagitis.
Epling J; Taylor H
J Fam Pract; 1999 Feb; 48(2):93-4. PubMed ID: 10037536
[No Abstract] [Full Text] [Related]
56. Omeprazole and acid peptic disease.
Piper DW; Yeomans ND; Shearman DJ
Med J Aust; 1991 Mar; 154(6):374-5. PubMed ID: 2000048
[No Abstract] [Full Text] [Related]
57. Omeprazole.
Walan A
Baillieres Clin Gastroenterol; 1988 Jul; 2(3):629-40. PubMed ID: 3048454
[No Abstract] [Full Text] [Related]
58. The use and abuse of histamine H2-receptor antagonists.
Milton-Thompson GJ
J R Nav Med Serv; 1977; 63(1):9-14. PubMed ID: 17005
[No Abstract] [Full Text] [Related]
59. Omeprazole in the treatment of ulcers induced by NSAIDs.
Langman MJ
Gut; 1998 Dec; 43(6):744-6. PubMed ID: 9824598
[No Abstract] [Full Text] [Related]
60. [A new H2-receptor antagonist in the treatment of gastrointestinal diseases].
Senfft U
Med Welt; 1982 Oct; 33(43):1516-8. PubMed ID: 6130463
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
